1.3 C
New York
Tuesday, January 31, 2023

This Is Too Hot For Pfizer Inc. (NYSE: PFE), Let’s Take A Closer Look

After Hours

There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. After-hours trades for Pfizer Inc. (PFE) shows that investor sentiment remained intact, with the stock’s consolidated last price rising by $0.10, or 0.22%, to $46.18. The Pfizer Inc. has recorded 1,382,033 volume in the after hours trading session. Most recently, Yahoo Finance reported about the stock as it publicized that Pfizer Expands ‘An Accord for a Healthier World’ Product Offering to Include Full Portfolio for Greater Benefit to 1.2 Billion People in 45 Lower-Income Countries.


Will You Miss Out On This Growth Stock Boom?

A new megatrend in the fintech market is well underway. Mobile payments are projected to boom into a massive $12 trillion market by 2028. According to Motley Fool this growth stock could "deliver huge returns." Not only in the immediate future but also over the next decade. Especially since the man behind this company is a serial entrepreneur who has been wildly successful over the years.

And this is just one of our 5 Best Growth Stocks To Own For 2023.

Sponsored

Stocks Info

As a NYSE listed company, PFE falls under the Healthcare sector while operating within the Drug Manufacturers – General industry segment. At the end of the last regular session, the stock closed at $46.08 and fluctuated between $46.74 as its day high and $45.71 as its day low. The current market capitalization of Pfizer Inc. is $257.90B. A total of 29.3 million shares were traded on the day, compared to an average of 21.14M shares.

Insider Activity

Aside from predicting where a stock will go, investors also consider insider trades as an indicator of the stock’s future direction. During the recent three months, PFE has seen 2 BUY and 0 SELL insider trades, representing the acquisition of 79,108 and the disposition of 0 shares. Over the last 12 months, there were 24 BUYs and 54 SELLs from insiders. Insiders purchased 1,184,419 shares during that period but sold 846,945.

In the most recent transaction, DAMICO JENNIFER B. sold 4,218 shares of PFE for 53.96 per share on Jun 07. After the transaction, the SVP & Controller now owns 10,846 company shares. In a previous transaction on May 16, DAMICO JENNIFER B. sold 4,000 shares at 50.50 per share. PFE shares that SVP & Controller owns now total 15,064.

Among the insiders who sold shares, SAHNI PAYAL disposed of 1,408 shares on May 13 at a per-share price of $49.84. This resulted in the Executive Vice President holding 17,372 shares of PFE after the transaction. In another insider transaction, Carapezzi William R JR sold 32,908 shares at $50.00 per share on May 12. Company shares held by the Executive Vice President now total 38,146.

Dividend

Investors prefer companies that pay dividends because dividends generate immediate cash flow and indicate a positive outlook. Pfizer Inc. pays an annual dividend of $1.64, resulting in a dividend yield of 3.56%, and it has a price to earnings (P/E) ratio of 8.74. PFE’s most recent ex-dividend date was 1/26/2023 when it declared a $0.41 quarterly dividend that was paid in cash on 3/3/2023. Previously, the company paid the dividend on 12/5/2022 with an ex-dividend date of 11/3/2022. The PFE stock dividend was $0.40 per share in cash.

In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. According to analysts who have offered 12-month price targets for PFE in the last 3 months, the mean price target is $55.12 with high estimates of $75.00 and low estimates of $44.00. In terms of 52-week highs and lows, PFE has a high of $56.32 and a low of $41.44.

As of this writing, PFE has an earnings estimate of $15.52 per share for the current quarter. EPS was calculated based on a consensus of 6 estimates, with a high estimate of $17.24 per share and a lower estimate of $13.98. The company reported an EPS of $18.41 in the last quarter, which was -0.20% lower than expectations of $18.44.

Balance Sheet Annually/Quarterly

The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects.

Analysts Opinion

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 22 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for PFE is Sell with a score of 4.09. A total of 10 analysts rated the stock as Buy while 0 rated it as Overweight while 12 rated it as Hold. Among the other participants, 0 thought the stock was Underweight and 0 thought it should be Sold.

Related Articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest Articles